Inhibition of CDK2 activity results in cell cycle arrest in human breast carcinoma cells34 and CDK9 inhibition subsequently causes the inactivation of RNAP II, resulting in cell apoptosis in multiple myeloma cells35. This evidence concerns the gene CDK2 and plasma cell myeloma.